# OnCo record murano (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/murano/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "murano", "NCT02005471" ;
  schema:name "MURANO"@en ;
  schema:description "MURANO showed that a fixed two-year course of the BCL2 inhibitor venetoclax with rituximab kept relapsed chronic lymphocytic leukaemia away for far longer than chemo-immunotherapy, and that many patients stayed in remission for years after stopping."@en ;
  schema:url <https://onco.cc/trials/murano/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02005471> ;
  onco:status "positive" ;
  onco:tag "subtype-trials" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/cll-relapsed/>, <https://onco.cc/cancers/cll/> ;
  onco:drugs <https://onco.cc/drugs/venetoclax/>, <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/bendamustine/> ;
  onco:companies <https://onco.cc/companies/roche-genentech/>, <https://onco.cc/companies/abbvie/> ;
  onco:people <https://onco.cc/people/john-seymour/> .